John Neiman (Tag Archives)
Subscribe to PricePlow's Newsletter and John Neiman Alerts
DMAA Banned From Supplements: Hi-Tech Pharmaceuticals Loses Appeal
Update April 17, 2020: Hi-Tech Pharma’s request for an En Banc Review (filed October 15, 2019) has been denied. See the Judge’s final response here.
This effectively ends the Hi-Tech DMAA Lawsuit, unless they were to somehow take this to the Supreme Court, which seems unlikely given the current political climate.
On August […]
Continue Reading →
September 22, 2014 · Updated April 17, 2020 Mike Roberto
in Supplement Industry News, Supplement News
| 14 Comments
DMAA FDA Lawsuit Appeal Oral Arguments: Hi-Tech Gets Their Day in Court
In March of 2018, we were left with Hi-Tech Pharmaceuticals’ appeal to the Eleventh Circuit court over their DMAA lawsuit against the FDA. Before we get into the update, a quick recap:
Hi-Tech appealed the ruling of district court judge Willis B. Hunt because he made his decision against them based upon information that neither[…]
Continue Reading →
